Tech Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal Jonathan Jeriah November 16, 2022 1 min read Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.Read More About The Author Jonathan Jeriah See author's posts Continue Reading Previous Previous post: ‘We’ve slotted him everywhere else and it hasn’t worked’: Why Huberdeau is on Flames 3rd lineNext Next post: Badenoch Calls for Green Investment to ‘Future-Proof’ UK Economy Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News What role should oil and gas companies play in climate tech? What role should oil and gas companies play in climate tech? August 9, 2025 How HR Uses AI to Stay Human How HR Uses AI to Stay Human August 9, 2025